Coined by Legueu and Dossot in 1931, the word ‘dysectasias’ encompasses all the faulty openings of the neck of the bladder. Besides prostatic lesions, there is no single ‘vesical prostatism’ – only disorders of the vesical neck leading to dysectasia. The clinical syndrome involves a progressive or acute dysuria, char- acterized by slowness in beginning micturition; sometimes pollakiuria; sometimes micturition in two phases (diverticulum); sometimes, unsuspected for a long time; chronic azotemia; conduct clinical-biological-radiological balance, negative of bladder : diverticular bladder; dilatation of upper apparatus; endoscopy, sometimes not needed, shows a trabecular bladder, incipient diverticula; raising of posterior lip of neck. Dysectasia may be congenital or acquired: It exists in the child, in the woman – often secondary to chronic factors of surroundings (progressive sclerosis). Treatment consists of opening the neck, endoscopic resection, simple fulguration in the female patient, endovesical ablation of the neck in the case of associated diverticula, and, finally, divulsion. Such are the therapeutic means to be discussed.

Keywords:
Disectasias, Resection, Dysuria, Diverticulum
This content is only available via PDF.
© 1972 S. Karger AG, Basel
1972
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.